Detection of survivin protein in aqueous humor and serum of retinoblastoma patients and its clinical significance

Clinical Biochemistry

Volumn 43, Issue 4-5, 2010, Pages 362-366

  Shehata, Hanan H ^a   Abou Ghalia, Azza H ^a   Elsayed, Eman K ^a   Ziko, Osman O ^a   Mohamed, Saffaa S ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Aqueous humor; Retinoblastoma; Survivin

Indexed keywords

SURVIVIN;

AQUEOUS HUMOR; ARTICLE; BLOOD SAMPLING; CANCER GRADING; CANCER STAGING; CHILD; CONTROLLED STUDY; CORRELATIONAL STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; EYE DISEASE; FEMALE; HUMAN; INFANT; MALE; OPTIC NERVE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; QUANTITATIVE ASSAY; REFERENCE VALUE; RETINOBLASTOMA; SENSITIVITY AND SPECIFICITY;

AQUEOUS HUMOR; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM STAGING; RETINOBLASTOMA; ROC CURVE;

EID: 76749109843     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.10.056     Document Type: Article

References (34)

1. Seregard S., Lundell G., Svedberg H., and Kivela T. Incidence of retinoblastoma from 1958 to 1998 in Northern Europe: advantages of birth cohort analysis. Ophthalmology 111 (2004) 1228-1232
2. Vogel F. Genetics of retinoblastoma. Hum. Genet. 52 (1979) 1-54
3. Harbour J.W., and Dean D.C. Rb function in cell-cycle regulation and apoptosis. Nat. Cell Biol. 2 (2000) 65-67
4. Honda R., Tanaka H., and Yasuda H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420 (1997) 25-27
5. Laurie N.A., Donovan S.L., Shih C.S., et al. Inactivation of the p53 pathway in retinoblastoma. Nature 444 (2006) 61-66
6. Lin P., and O'Brien J.M. Frontiers in the management of retinoblastoma. Am. J. Ophthalmol. 148 (2009) 192-198
7. Abramson D.H. Retinoblastoma in the 20th century: past success and future challenges the Weisenfeld lecture. Invest. Opthalmol. Vis. Sci. 46 (2005) 2683-2691
8. Poulaki V., Mitsiades C.S., Joussen A.M., Lappas A., Kirchhof B., and Mitsiades N. Constitutive nuclear factor-kappa B activity is crucial for human retinoblastoma cell viability. Am. J. Pathol. 161 (2002) 2229-2240
9. Johnson M.E., and Howerth E.W. Survivin: a bifunctional inhibitor of apoptosis protein. Vet. Pathol. 41 (2004) 599-607
10. Crook N.E., Clem R.J., and Miller L.K. An apoptosis-inhibiting gene with a zinc finger-like motif. J. Virol. 67 (1993) 2168-2174
11. Nakayama K., and Kamihira S. Survivin an important determinant for prognosis in adult T-cell leukemia: a novel biomarker in practical hemato-oncology. Leuk. Lymphoma 43 (2002) 2249-2255
12. Sasaki T., Lopes M.B., Hankins G.R., and Helm G.A. Expression of survivin, an inhibitor of apoptosis protein in tumors of the nervous system. Acta Neuropathol. 104 (2002) 105-109
13. Cao M., Yie S.M., Wu S.M., et al. Detection of survivin-expressing circulating cancer cells in the peripheral blood of patients with esophageal squamous cell carcinoma and its clinical significance. Clin. Exp. Metastasis (2009) Jun 12
14. Ambrosini G., Adida C., and Altieri D.C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 3 (1997) 917-921
15. Chantalat L., Skoufias D.A., Kleman J.P., Jung B., Dideberg O., and Margolis R.L. Crystal structure of human survivin reveals a bow tie-shaped dimer with two unusual alpha-helical extensions. Mol. Cell 1 (2000) 183-189
16. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
17. Altieri D.C. The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol. Med. 7 (2001) 542-547
18. Wang T., Qian X.P., and Liu B.R. Survivin: potential role in diagnosis, prognosis and targeted therapy of gastric cancer. World J. Gastroenterol. 13 (2007) 2784-2790
19. Raj D., Liu T., Samadashwily G., Li F., and Grossman D. Survivin repression by p53, Rb and E2F2 in normal human melanocytes. Carcinogenesis 29 (2008) 194-201
20. Hattori M., Sakamoto H., Satoh K., and Yamamoto T. DNA demethylase is expressed in ovarian cancers and the expression correlates with demethylation of CpG sites in the promoter region of c-erbB-2 and survivin genes. Cancer Lett. 169 (2001) 155-164
21. Xu Y., Fang F., Ludewig G., Jones G., and Jones D. A mutation found in the promoter region of the human survivin gene is correlated to over expression of survivin in cancer cells. DNA Cell Biol. 23 (2004) 527-537
22. Zhao J., Tenev T., Martins L.M., Downward J., and Lemoine N.R. The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner. J. Cell. Sci. 113 (2000) 4363-4371
23. Gianani R., Jarboe E., Orlicky D., et al. Expression of survivin in normal, hyperplastic, and neoplastic colonic mucosa. Hum. Pathol. 32 (2001) 119-125
24. Jiang L.B., Liu X.Q., Li B., et al. Heat shock proteins and survivin: relationship and effects on proliferation index of retinoblastoma cells. Histol. Histopathol. 23 (2008) 827-831
25. Rousseau A., Kujas M., Bergemer-Fouquet A.M., van Effenterre R., and Hauw J.J. Survivin expression in ganglioglioma. J. Neurooncol. 77 (2006) 153-159
26. Xiang X.J., He Y.J., Li Y.H., Huang H., and Xu F. Clinical significance of survivin expression in peripheral T-cell lymphoma. Ai Zheng 25 (2006) 758-761
27. Li Y.H., Hu C.F., Shao Q., et al. Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma. J. Transl. Med. 6 (2008) 1
28. Goksel G., Taneli F., Uslu R., et al. Serum her-2/neu and survivin levels and their relationship to histological parameters in early-stage breast cancer. J. Int. Med. Res. 35 (2007) 165-172
29. Wang Z.N., Xu H.M., Jiang L., Zhou X., Lu C., and Zhang X. Expression of survivin mRNA in peritoneal lavage fluid from patients with gastric carcinoma. Chin. Med. J. 117 (2004) 1210-1217
30. Ziaee S.A., Moula S.J., Hosseini Moghaddam S.M., and Eskandar-Shiri D. Diagnosis of bladder cancer by urine survivin, an inhibitor of apoptosis: a preliminary report. Urol. J. 3 (2006) 150-153
31. Wu Y.K., Chen K.T., Kuo Y.B., Huang Y.S., and Chan E.C. Quantitative detection of survivin in malignant pleural effusion for the diagnosis and prognosis of lung cancer. Cancer Lett. 273 (2009) 331-335
32. Hoffmann A.C., Warnecke-Eberz U., Luebke T., et al. Survivin mRNA in peripheral blood is frequently detected and significantly decreased following resection of gastrointestinal cancers. J. Surg. Oncol. 95 (2007) 51-54
33. Wang J., Huang C., Wei X.Y., et al. Changes of activated circulating endothelial cells and survivin in patients with non-small cell lung cancer after antiangiogenesis therapy. Chin. Med. J. 121 (2008) 2234-2240
34. Guney N., Soydine H.O., Derin D., et al. Serum and urine survivin levels in breast cancer. Med. Oncol. 23 (2006) 335-340